TIMD4 and neoplasm: A recent study has shown that PRMs express high levels of Tim4, which are associated with reduced levels of CD8+ T cells with tumor-reactive features in pleural effusions and peritoneal ascites from patients with lung cancer (Chow et al., 2021).